Pancreatic Cancer Research

ResearcherNorth Sichuan Medical UniversityActive in the last 2 years

Yong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7971-4871; OpenAlex author ID A5100355304. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study. Co-author DOI 10.3389/fonc.2025.1521616↗
  2. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer. Co-author DOI 10.3389/fimmu.2024.1341209↗
  3. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma. Last author DOI 10.1007/s00464-022-09441-1↗
  4. Identifying Outcomes of Patients With Advanced Pancreatic Adenocarcinoma and RECIST Stable Disease Using Radiomics Analysis. Co-author DOI 10.1200/po.21.00362↗
  5. Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study. First author DOI 10.21037/qims-22-112↗
  6. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Co-author DOI 10.1038/s43018-020-00134-z↗
  7. Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis. Last author DOI 10.1177/0284185120907246↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guangnian Zhang · 2 shared papers, 2024–2025 · strength 0.42
  2. Jun Qing Yu · 2 shared papers, 2024–2025 · strength 0.42
  3. Jianshui Li · 2 shared papers, 2024–2025 · strength 0.42
  4. Dawei Deng · 2 shared papers, 2024–2025 · strength 0.42
  5. Chuan Lan · 2 shared papers, 2024–2025 · strength 0.42
  6. Yi Chen · 1 shared paper, 2025 · strength 0.22
  7. Jisheng Zhu · 1 shared paper, 2023 · strength 0.22
  8. Weidong Xiao · 1 shared paper, 2023 · strength 0.22
  9. Yifu Hou · 1 shared paper, 2024 · strength 0.20
  10. Dongmei Ren · 1 shared paper, 2024 · strength 0.20
  11. Mengyue Tang · 1 shared paper, 2022 · strength 0.15
  12. Xiaoming Zhang · 1 shared paper, 2022 · strength 0.15
  13. Yize Mao · 1 shared paper, 2022 · strength 0.15
  14. Tao Qin · 1 shared paper, 2022 · strength 0.15
  15. Qiuxia Yang · 1 shared paper, 2022 · strength 0.15
  16. Yan Deng · 1 shared paper, 2022 · strength 0.15
  17. Lizhi Liu · 1 shared paper, 2022 · strength 0.15
  18. Rong Zhang · 1 shared paper, 2022 · strength 0.15
  19. Yong Chen · 1 shared paper, 2022 · strength 0.15
  20. Renye Que · 1 shared paper, 2020 · strength 0.13
  21. Meilian Zhuo · 1 shared paper, 2021 · strength 0.10
  22. Xun Lan · 1 shared paper, 2021 · strength 0.10
  23. Mo Chen · 1 shared paper, 2021 · strength 0.10
  24. Wenze Wang · 1 shared paper, 2021 · strength 0.10
  25. Junya Peng · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.